Adicet Bio (ACET) Enterprise Value (2017 - 2026)
Adicet Bio (ACET) posted quarterly Enterprise Value of -$137.6 million for Q1 2026, up 8.54% year-over-year from -$126.8 million in Q1 2025, and up 13.21% quarter-over-quarter from -$158.5 million in Q4 2025.
Adicet Bio (ACET) Enterprise Value (2017 - 2026) Analysis & Trends
Adicet Bio's Enterprise Value history runs 10 years deep, the most recent figure standing at -$137.6 million for Q1 2026.
- In Q1 2026, Enterprise Value rose 8.54% year-over-year to -$137.6 million; the TTM figure through Mar 2026 stood at -$137.6 million (up 8.54% YoY), while the FY2025 annual figure was -$158.5 million, up 10.08% from the prior year.
- Enterprise Value for Q1 2026 stood at -$137.6 million, up from -$158.5 million in the prior quarter.
- The five-year high for Enterprise Value was -$103.1 million in Q3 2025, with the low at -$282.7 million in Q3 2022.
- The 5-year median for Enterprise Value is -$183.3 million (2023), against an average of -$193.9 million.
- The sharpest annual moves came in 2022 and 2025: Enterprise Value plunged 47.06% in 2022, then jumped 48.98% in 2025.
- Adicet Bio's Enterprise Value stood at -$257.7 million in 2022, then surged by 38.01% to -$159.7 million in 2023, then declined by 10.39% to -$176.3 million in 2024, then climbed by 10.08% to -$158.5 million in 2025, then grew by 13.21% to -$137.6 million in 2026.
- Business Quant data shows ACET's Enterprise Value at -$137.6 million in Q1 2026, -$158.5 million in Q4 2025, and -$103.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.83 Bn | 130.98 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 85.79 Bn | 77.79 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.95 Bn | 59.77 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 58.59 Bn | 53.46 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.93 Bn | 36.83 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 31.52 Bn | 28.21 Bn | 992.69 Mn | -3.31 Bn |
| 7 | BioNTech SE | 27.98 Bn | 9.58 Bn | 668.28 Mn | -18.39 Bn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn | -1.16 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 2.12 Bn |
| 10 | Adicet Bio | 99.02 Mn | -19.17 Mn | - | -118.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -118.19 Mn |
| Mar 31, 2026 | -137.59 Mn |
| Dec 31, 2025 | -158.53 Mn |
| Sep 30, 2025 | -103.10 Mn |
| Jun 30, 2025 | -124.96 Mn |
| Mar 31, 2025 | -150.44 Mn |
| Dec 31, 2024 | -176.30 Mn |
| Sep 30, 2024 | -202.07 Mn |
| Jun 30, 2024 | -224.07 Mn |
| Mar 31, 2024 | -159.71 Mn |
| Dec 31, 2023 | -159.71 Mn |
| Sep 30, 2023 | -183.26 Mn |
| Jun 30, 2023 | -205.46 Mn |
| Mar 31, 2023 | -231.64 Mn |
| Dec 31, 2022 | -257.66 Mn |
| Sep 30, 2022 | -282.68 Mn |
| Jun 30, 2022 | -260.64 Mn |
| Mar 31, 2022 | -277.88 Mn |
| Dec 31, 2021 | -277.54 Mn |
| Sep 30, 2021 | -192.23 Mn |